tert-butyl (2S,4S)-4-(4-(3-amino-1H-indazol-6-yl)-1H-1,2,3-triazol-1-yl)-2-((4-bromophenyl)carbamoyl)pyrrolidine-1-carboxylate

ID: ALA5203127

Chembl Id: CHEMBL5203127

PubChem CID: 168292755

Max Phase: Preclinical

Molecular Formula: C25H27BrN8O3

Molecular Weight: 567.45

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C)OC(=O)N1C[C@@H](n2cc(-c3ccc4c(N)n[nH]c4c3)nn2)C[C@H]1C(=O)Nc1ccc(Br)cc1

Standard InChI:  InChI=1S/C25H27BrN8O3/c1-25(2,3)37-24(36)33-12-17(11-21(33)23(35)28-16-7-5-15(26)6-8-16)34-13-20(30-32-34)14-4-9-18-19(10-14)29-31-22(18)27/h4-10,13,17,21H,11-12H2,1-3H3,(H,28,35)(H3,27,29,31)/t17-,21-/m0/s1

Standard InChI Key:  LEPJLENCQXRNFB-UWJYYQICSA-N

Alternative Forms

  1. Parent:

    ALA5203127

    ---

Associated Targets(Human)

ABL1 Tclin Bcr/Abl fusion protein (1667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562/Adr (229 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 567.45Molecular Weight (Monoisotopic): 566.1389AlogP: 4.36#Rotatable Bonds: 4
Polar Surface Area: 144.05Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.22CX Basic pKa: 3.40CX LogP: 3.90CX LogD: 3.90
Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.33Np Likeness Score: -1.47

References

1. Pan X, Liu N, Liu Y, Zhang Q, Wang K, Liu X, Zhang J..  (2022)  Design, synthesis, and biological evaluation of trizole-based heteroaromatic derivatives as Bcr-Abl kinase inhibitors.,  238  [PMID:35561654] [10.1016/j.ejmech.2022.114425]

Source